These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23259429)

  • 21. Image-guided dose-escalated intensity-modulated radiation therapy for prostate cancer: treating to doses beyond 78 Gy.
    Eade TN; Guo L; Forde E; Vaux K; Vass J; Hunt P; Kneebone A
    BJU Int; 2012 Jun; 109(11):1655-60. PubMed ID: 22035373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose radiotherapy with or without androgen deprivation therapy for intermediate-risk prostate cancer: cancer control and toxicity outcomes.
    Edelman S; Liauw SL; Rossi PJ; Cooper S; Jani AB
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1473-9. PubMed ID: 22245201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benchmarking dosimetric quality assessment of prostate intensity-modulated radiotherapy.
    Senthi S; Gill SS; Haworth A; Kron T; Cramb J; Rolfo A; Thomas J; Duchesne GM; Hamilton CH; Joon DL; Bowden P; Foroudi F
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):998-1005. PubMed ID: 21310548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Late toxicity after intensity-modulated radiation therapy for localized prostate cancer: an exploration of dose-volume histogram parameters to limit genitourinary and gastrointestinal toxicity.
    Pederson AW; Fricano J; Correa D; Pelizzari CA; Liauw SL
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):235-41. PubMed ID: 21163587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Benefit of intensity modulated and image-guided radiotherapy in prostate cancer].
    Latorzeff I; Mazurier J; Boutry C; Dudouet P; Richaud P; de Crevoisier R
    Cancer Radiother; 2010 Oct; 14(6-7):479-87. PubMed ID: 20797889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiation dose escalation for localized prostate cancer: intensity-modulated radiotherapy versus permanent transperineal brachytherapy.
    Wong WW; Vora SA; Schild SE; Ezzell GA; Andrews PE; Ferrigni RG; Swanson SK
    Cancer; 2009 Dec; 115(23):5596-606. PubMed ID: 19670452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical response after 3-d conformal radiotherapy of localized prostate cancer to a total dose of 66 gy 4-year results.
    Wachter-Gerstner N; Wachter S; Goldner G; Nechvile E; Pötter R
    Strahlenther Onkol; 2002 Oct; 178(10):542-7. PubMed ID: 12386785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contemporary prostate cancer radiation therapy in the United States: Patterns of care and compliance with quality measures.
    Lee DJ; Barocas DA; Zhao Z; Huang LC; Koyama T; Resnick MJ; Conwill R; McCollum D; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hashibe M; Kaplan SH; Paddock LE; Stroup AM; Wu XC; Penson DF; Hoffman KE
    Pract Radiat Oncol; 2018; 8(5):307-316. PubMed ID: 30177030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns of practice in intensity-modulated radiation therapy and image-guided radiation therapy for prostate cancer in Japan.
    Nakamura K; Akimoto T; Mizowaki T; Hatano K; Kodaira T; Nakamura N; Kozuka T; Shikama N; Kagami Y
    Jpn J Clin Oncol; 2012 Jan; 42(1):53-7. PubMed ID: 22131339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-escalation using intensity-modulated radiotherapy for prostate cancer--evaluation of the dose distribution with and without 18F-choline PET-CT detected simultaneous integrated boost.
    Pinkawa M; Attieh C; Piroth MD; Holy R; Nussen S; Klotz J; Hawickhorst R; Schäfer W; Eble MJ
    Radiother Oncol; 2009 Nov; 93(2):213-9. PubMed ID: 19717197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer.
    Teh BS; Dong L; McGary JE; Mai WY; Grant W; Butler EB
    Med Dosim; 2005; 30(1):25-30. PubMed ID: 15749008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electromagnetic transponders indicate prostate size increase followed by decrease during the course of external beam radiation therapy.
    King BL; Butler WM; Merrick GS; Kurko BS; Reed JL; Murray BC; Wallner KE
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1350-7. PubMed ID: 20605348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of pretreatment prostate volume on severe acute genitourinary toxicity in prostate cancer patients treated with intensity-modulated radiation therapy.
    Aizer AA; Anderson NS; Oh SC; Yu JB; McKeon AM; Decker RH; Peschel RE
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):379-84. PubMed ID: 20452135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PET and PET/CT in radiation treatment planning for prostate cancer.
    Pinkawa M; Eble MJ; Mottaghy FM
    Expert Rev Anticancer Ther; 2011 Jul; 11(7):1033-9. PubMed ID: 21806327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcomes of 60 Gy conventional radiotherapy combined with androgen deprivation for localized or locally advanced prostate cancer.
    Hashine K; Numata K; Azuma K; Sumiyoshi Y; Kataoka M
    Jpn J Clin Oncol; 2005 Nov; 35(11):655-9. PubMed ID: 16275680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose constraint for minimizing grade 2 rectal bleeding following brachytherapy combined with external beam radiotherapy for localized prostate cancer: rectal dose-volume histogram analysis of 457 patients.
    Shiraishi Y; Yorozu A; Ohashi T; Toya K; Seki S; Yoshida K; Kaneda T; Saito S; Nishiyama T; Hanada T; Shigematsu N
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e127-33. PubMed ID: 21398047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intensity-modulated radiation therapy: supportive data for prostate cancer.
    Cahlon O; Hunt M; Zelefsky MJ
    Semin Radiat Oncol; 2008 Jan; 18(1):48-57. PubMed ID: 18082588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rectal dose constraints for intensity modulated radiation therapy of the prostate.
    Swanson GP; Stathakis S
    Am J Clin Oncol; 2011 Apr; 34(2):188-95. PubMed ID: 20622649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.
    Vargas C; Martinez A; Kestin LL; Yan D; Grills I; Brabbins DS; Lockman DM; Liang J; Gustafson GS; Chen PY; Vicini FA; Wong JW
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1297-308. PubMed ID: 16029785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.
    Hong TS; Tomé WA; Jaradat H; Raisbeck BM; Ritter MA
    Acta Oncol; 2006; 45(6):717-27. PubMed ID: 16938815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.